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The catalytic effect of D68N mutant in Thermococcus thioreducens Inorganic
Pyrophosphatase

Zeina Sleiman
Dr. Joseph Ng

Abstract
Inorganic Pyrophosphatase (IPPase) from Thermococcus thioreducens catalyzes the hydrolysis
of Inorganic Pyrophosphatase to produce Orthophosphate. Even though IPPase is a universal
enzyme, the mechanism of catalysis is not completely known. Aspartate 68 (D68) is one of 13
conserved residues in the active site of IPPase across all domains of life. The function of D68 in
the mechanism of catalysis is not clear. To elucidate the of D68, a recombinant mutant of IPPase
containing and Asparagine in place of Aspartate at position 68 (D68N) was isolated and purified.
The catalytic activity of the D68 mutant will be compared with that of the wild-type. By
coupling molecular modeling and enzymatic studies of D68N mutant, the structural and
functional role of Asp 68 can be further understood.
Introduction
Inorganic Pyrophosphatase (IPPase) is an important enzyme found universally throughout all
organisms. The importance of this enzyme is in its ability to regulate the concentration of
inorganic pyrophosphate by hydrolyzing organic pyrophosphate. Inorganic pyrophosphate is a
byproduct of many biosynthesis reactions like protein synthesis and if left unregulated would
lead to an imbalance of the cell’s physiology. IPPase is present in organisms in three different
nonhomologous categories: Family I, Family II, and Family III. Even though the enzymes
perform the same type of catalysis, there are dissimilarities in both structure and mechanism. For
the purpose of this study, Family II is studied to effectively decipher the mechanism through
mutagenesis.
Family II is structurally and mechanistically different from the other Families and is only found
in archaebacteria and bacterial lines including human pathogenic bacteria (Tommi et al. 2013),
(Baykov et al. 2017). The distribution of sequenced Family IPPase II has revealed 499 in
Firmicutes and 228 found in Proteobacteria (Baykov et al. 2017). Also, due to only being
recently identified in the past 20 + years, some mechanistic properties are still ambiguous, but
the structure is known. Family II IPPase is a homodimer and the protein’s active site is in a
conserved region of Asp-His-His motif that holds the crucial metal ions of Mn2+. This conserved
region is conserved motif found in the “DHH phosphoeterase superfamily” that consisted of
multiple other enzymes like single-stranded DNA exonuclease (Baykov et al. 2017).
The current uncompleted mechanism begins with a water molecule on the DHH domain laying a
nucleophilic attack on the electrophilic phosphate group (Baykov et al. 2017). This is done by
the unique center made by the water and the three metal ions causing a rearrangement of the
water molecule rearranging 1 Å from the binding of the electrophilic phosphate substrate. This
stabilizing rearrangement could only be done with metals. The whole mechanism is done cleanly
without an intermediate, which is common throughout the other two families
It is suggested that the enzyme’s use of Mn2+, with its higher affinity to the active site, instead of
Mg2+ is the reason for the higher rate of catabolism kinetically at kcat ≅ 2000s-1 (Tommi et al.
2013). Due to the differences in the structure of Family II IPPase, it can be safely be assumed
that the mechanism of the catalysis is different. It is suggested because of the various metal ion
coordination differences; the hydrolysis is done with a “dissociative mechanism” rather than an

associative mechanism. This mechanism is done by an electrophile with influencing the
hydroxide ion of a water molecule for a nucleophile attack of the substrate.
The stabilization by the second metal is poorly understood and this is the area being studied by
using point mutation of various parts of the conserved active site. Particularly the 68th amino
acid, aspartate (D68), coordinates with the pyrophosphate to activate the substrate into an
electrophile to be stabilized by the metal ion in question. By mutating the aspartate, the
occupation and importance of the amino acid to the mechanism with the metal ion stabilization
will be better understood. This study focuses on the mutation of D68 to an asparagine (D68N)
switching the original negative side chain to a positive side chain in hopes of observing a change
in the mechanism through an enzyme activity assay.
IPPase Family II is found in some pathogenic bacteria and by understanding the catlysism and
possible inhibition of enzyme, it would be possible to manipulate. By manipulating the enzyme
with the mechanism and function, it might become increasingly possible to bring about another
defense against pathogenic diseases in this era of antibiotic resistant bacteria.
Materials and Methods
Transformation
Firstly, a plasmid that contains both antibiotic resistance against chloramphenicol and
carbenicillin as well as the DNA sequencing for Thermococcus thioreducens Inorganic
Pyrophosphatase (IPPase) is added to a solution of competent E. coli cells. This DNA sequence
would also contain the antibiotic resistance that would ensure growth of the expressing bacteria.
These cells are kept in a -80 ℃ freezer and must thaw over ice for one-time use. The DNA
sequence is added in a 1:25 volume: volume ratio with the cells and allowed to incubate on ice
for 20 minutes. Once these cells are incubated, they are placed in a 42 ℃-heat shock to activate
the cells for DNA acceptance. Then the cells are suspended in 1 mL LB Miller broth which will
supply the nutrients necessary for the cell’s growth. This growth takes place in a 37 ℃-water
bath for 45 minutes. This now turbid cell solution then has 1 mL poured over an agar plate that
contains 50 µg/mL carbenicillin and 30mg/mL chloramphenicol. Cells were then allowed to
grow over night on the plates.
Small Scale Inoculation
Upon formation of cell colonies, production of IPPase must be screened for. Half the colony was
inoculated into 25 mL LB Miller media with the same antibiotic concentration as the agar plate.
Once the cells were grown, protein was roughly purified through heat cut and protein expression
of the different colonies were portrayed through an SDS-PAGE. When overexpression of IPPase
at the 21 kDa range was present, the other half of the colony would be used for a large scale
inoculation.
Large Scale Inoculation
Half of the colonies were inoculated each into 125 mL volumetric flasks containing 50 mL of
sterilized LB miller broth, 50 mg/mL chloramphenicol, and 100 mg/mL carbenicillin. The flasks

were left to incubate at 37 ℃ in a shaker overnight. After 21 hours, 10 mL of the now turbid
solution is transferred to a 4000 mL volumetric flask containing 1000 mL of sterilized LB miller,
50 mg/mL chloramphenicol, and 100 mg/mL carbenicillin. The flasks were left to be incubated
at 37 ℃ in a shaker. The absorbance was checked at every hour at 600 nm to determine the
moment before the bacteria start their exponential growth estimated to be at an absorbance of
0.300. After 3 hours and 20 minutes, bacteria solution reached desired absorbance. At this time,
the temperature was dropped to 30 ℃ and the operon IPTG was added for an overall
concentration of 0.5 mM. The solution was left to shake overnight.
Lysing Bacteria
The turbid solution transferred into four 250 mL centrifuge bottles and balanced. The solution
was centrifuged down at 6000 rcf at 25℃ for 7 minutes. After centrifuging, bacterial pellets were
collected and weighed into no more than 10 g pellets and plastic wrapped. The 10g mass was
found to be the optimal size for protein concentration while not overloading a 40 mL anion
exchange column. The pellet was stored at -80℃ overnight. The pellet was unwrapped frozen
and resuspended into 50 mL lysis buffer of 25mM NaCl, 2 mM EDTA, 1 mM PMSF, 0.1 mg/mL
lysozyme, and 50 mM HEPES pH 7.5. Once resuspended, the bacteria were further lysed using
sonication for 10 minutes, 10 seconds on and 20 seconds off cycles until solution is
homogeneous. The sonicated solution is transferred into round bottom centrifuge tubes and
centrifuged for 1 hour at 4 ℃ and 6000 rcf. The supernatant was collected, and the cell debris
pellet disposed.
Heat Cut
The supernatant was transferred into a 125 mL volumetric flask, where a DNase stock solution
was added at 500 µL per 100 mL. Then, the solution was allowed to incubate at room
temperature for 30 minutes. Afterwards, the flask was placed in a 72 ℃-water bath for 45
minutes. The heat cut solution is transferred into round bottom centrifuge tubes and centrifuged
for 1 hour at 4 ℃ and at 6000 rcf. The supernatant is collected into conical tubes and the pellet
disposed.
Anion Exchange Column
A 160 mL Q-sepharose column was charged with a resolving buffer consisting of 50 mM
HEPES buffer pH 7.5, 50 mM NaCl, 1 mM PMSF, and 1 mM EDTA at a 2 mL/ minute flow
rate. Once the column was charged the protein sample was loaded onto the column and a linear
gradient buffer of 10 times column volume switch was started. This buffer switch consists of a
change from the resolving buffer to an identical 1 M NaCl concentration elution buffer. During
this linear gradient, fractions of a 10 mL volume were collected and tested in a nanodrop as well
as an SDS-PAGE for protein concentration. These tested fractions would later be combined and
concentrated for size exclusion chromatography.
Size Exclusion
The samples are concentrated down by spinning down the solution in a 10 kDa concentrator tube
that is spun down in a centrifuge at 4 ℃, 5000 rcf for 20 minutes. The protein sample is

concentrated down to a volume of 500 µL before being carefully pipetted evenly onto a 120mL
S100 size exclusion column. A 25 mM HEPES 100mM NaCl buffer was ran through the column
to both charge it before the sample was loaded, and run with the sample both at 1 mL/min. Once
the concentrated sample was loaded onto the column 10 mL fractions were collected and tested
on the nanodrop for protein concentration.
Enzyme Activity Assay
For the assay, multiple reagents were made. Reagent A was made with 50mM Tris-HCl solution
brought to basic pH of 9.0 with concentrated 15 M NaOH. Reagent B is a 10 mM Sodium
Pyrophosphate solution that was made with Pyrophosphate tetrasodium. Reagent C is a 10 mM
Magnesium Chloride solution. Reagent D is a 10% Ammonium molybdate solution in 10N
Sulfuric acid. This solution was made by diluting concentrated sulfuric acid 36N to 10N and
dissolving 5g of Ammonium molybdate in 10N sulfuric acid diluting to 50 mL. The last reagent,
reagent E, dissolves 5g of Ferrous sulfate in 10 mL of Reagent D and diluting to 100mL with
deionized water.
First, the standard curve was made using a 96 well plate. Deionized water was added in
decreasing increments of 1µL starting at 150 µL and ending the 11th well with 140 µL. the
substrate reagent, 10nmol/µL Sodium Pyrophosphate, was added at increasing increments of 1
µL starting the first well at 0 µL ending the 11th well at 10 µL. The last Reagent added was
Reagent D with 150 µL in each plate to total each well at 300 µL. Afterwards, the wells were
incubated at room temperature for 10 minutes. After the incubation, the well plate was assayed
with a spectrophotometer and read at an Absorbance of 660nm. The data was recorded and
graphed.
The samples were constructed in Eppendorf tubes before being transferred to 96 well plate as
well using the viable fractions from the size exclusion. The solution was arranged with 40 µL of
the Reagent A added in 0.5 mL Eppendorf tubes followed by 10 mL of Reagent B and 10 mL of
Reagent C. Lastly, 1 µL of the enzyme sample from the size exclusion fraction was added and
the solutions were incubated for 30 minutes in a 72ºC water bath. The blank was made similarly
but with 41 µL Reagent A and no enzyme sample. After the incubation, 145 µL of deionized
water was added to the wells along with 5 µL of the incubated sample and 150 µL of Reagent E
for a final volume of 300 µL in each well plate. The plate was incubated at room temperature for
10 minutes before being assay with a spectrophotometer at an Absorbance of 660 nm. The value
were recorded and the Specific Activity was calculated.

Results
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Figure 1 SDS – PAGE for Wild Type IPPase containing protein expression for Crude
Lysate, Post Heat Cut, Unbound from Anion Exchange, Post Anion Exchange, and Size
Exclusion Fractions
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Figure 2 SDS – PAGE for D68N IPPase containing protein expression for Crude Lysate,
Post Heat Cut, Unbound from Anion Exchange, Post Anion Exchange, and Size
Exclusion Fractions

In an SDS - PAGE, protein is denatured and run through the gel. Tt IPPase is found in the 21
kDa region. In both Figure 1 and 2, the protein purification process appear qualitatively to be
working with the band for IPPase becoming more concentrated
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Figure 3 Anion Exchange purification of Wild Type IPPase portraying the Fractions that
were eventually combined and the separation of the DNA contamination.

Figure 4 Anion Exchange purification of D68N IPPase portraying the Fractions that
were eventually combined and the separation of the DNA contamination.

With the peaks being cut off due to machine limitations, nanodrop readings and SDS-PAGE of
each fractions was necessary for determining which fractions would be conserved for size
exclusion. A high A280/260 ratio would signify high protein presence. A280 refers to
absorbance of UV light that is emitted by tryptophan amino acids at a wavelength of 280 nm,
while A260 refers to an absorbance due to nucleotides. Those with high IPPase (21 kDa)
expression were concentrated down for size exclusion gel filtration.

Figure 5 Size Exclusion Purification Wild Type IPPase

Figure 6 Size Exclusion purification D68N IPPase

An S100 chromatography column separates proteins based on weight up to 100 kDa, allowing
larger proteins to flow through and be collected in earlier fractions, while smaller proteins would
pe trapped in the gel and take longer to elute off. Nanodrop and SDS-PAGE of the fractions
determined where the IPPase had eluted off. Both Figure 5 and 6 have peaks eluting at the same
time identifying the exact time protein will likely elute off.

Figure 7 Standard Curve of Enzyme Activity Assay
Samples

Blank

WT
WT
D68N
D68N
D68N
Fraction 7 Fraction 9 Fraction 7 Fraction 8 Fraction 9
0.141
0.141
0.150
0.134
0.145

A660
0.000
Concentration
19.709
19.709
(µmol)
Specific
Activity
120.227
120.227
(µmol/min)
Table 1 Values of Enzyme Activity Assay

20.756

18.895

20.174

126.610

115.262

123.0

Discussion
In this study, an enzyme activity assay was used as the determinant of the possible activity or
inactivity of the mutated D68N IPPase compared to the Wild Type IPPase. As seen in Table 1,
there is a difference in activity between the mutant and the Wild Type, but their cannot be any
hard conclusions on the activity of the enzyme, There appears to be a change catalysys of the
substrate, Inorganic Pyrophosphatase, but there is not a clear sign of complete inactivity of the
D68N enzyme. Without the inactivity, it maybe possible that the D68 amino acid is not critical
in the stabilization of the metal ion meaning that another study must be made mutating another
amino acid in the conserved active site to distinguish the mechanism of the hydrolyzation of
inorganic pyrophosphatase with IPPase.
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